Anuh Pharma Limited has informed the Exchange regarding the approval of Un-audited Financial Results for the period ended September 30, 2025 and Adoption of revised policies of the Company.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has informed the stock exchange that its Board has approved the unaudited financial results for the quarter and half-year ended September 30, 2025. Alongside the results, the Board has also adopted revised policies of the Company. No specific financial figures (such as revenue, profit after tax, or margins) are mentioned in this filing headline. The detailed results would typically be available in the accompanying financial result document. The policy revision is a routine corporate governance step but the nature of the revised policies has not been disclosed in this announcement.
This is a procedural disclosure confirming Board approval of Q2 FY26 results, which is a regulatory requirement. Investors should review the detailed financial result document for actual revenue, profit, and margin performance. The revision of company policies is typically administrative but could have governance implications depending on which policies were changed.